Chemotherapy of cancer of the head and neck.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002404:Catheterization / Q000009:adverse effects; D003520:Cyclophosphamide / Q000627:therapeutic use; D005971:Glutamates / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D002955:Leucovorin / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D011621:Pteridines / Q000627:therapeutic use; D012075:Remission, Spontaneous
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D005971:Glutamates; D011621:Pteridines; D001761:Bleomycin; D003520:Cyclophosphamide; D002955:Leucovorin; D006918:Hydroxyurea; D008727:Methotrexate